Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia News Guide.
Press releases published on August 6, 2025
Redefining Financial Reporting: Chartered Institute Launches CIFRS™ Certification for Financial and Accounting Leaders
EIN Presswire
·
August 6, 2025
Chartered Institute of Professional Certifications Introduces the Accredited CIFRS™ Program for Finance, Accounting, and Reporting Professionals SINGAPORE, SINGAPORE, SINGAPORE, August 6, 2025 /EINPresswire.com/ -- The Chartered Institute of …
AIM ImmunoTech’s Oncology Drug Ampligen to Be Featured in Key Presentations and Abstract at the International 5th Annual Marie Skłodowska-Curie Symposium on Cancer Research and Care (MSCI MSCS-2025)
GlobeNewswire
·
August 6, 2025
There will be presentations on the latest positive progress from AIM’s clinical program in pancreatic cancer, the positive therapeutic effects of AIM’s drug Ampligen on multiple cancer types, and Ampligen’s mechanism of action in oncology Discussion will …
VCI Global Appoints Dr. Chan as Chief AI & Data Officer to Accelerate Enterprise Strategy
GlobeNewswire
·
August 6, 2025
KUALA LUMPUR, Malaysia, Aug. 06, 2025 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (“VCI Global” or the “Company”), today announced the appointment of Dr. Chan Wai Mun as Chief AI …
Allogene Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update
GlobeNewswire
·
August 6, 2025
Conference Call and Webcast Scheduled for August 13, 2025 at 2:00 p.m. PT/5:00 p.m. ET SOUTH SAN FRANCISCO, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the …
Veru Announces Reverse Stock Split
GlobeNewswire
·
August 6, 2025
MIAMI, FL, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced that it will …
RenovoRx Expands U.S. Commercialization Efforts for the RenovoCath® Device with Growing Customer Demand and Key Leadership Hire
GlobeNewswire
·
August 6, 2025
RenovoRx increases its commercial footprint to thirteen leading National Cancer Institute-designated and community centers approved to purchase RenovoCath Four active cancer center customers are currently purchasing and have made repeat orders of …
Cheer Holding Issues Correction to 2025 Half Year Results
GlobeNewswire
·
August 6, 2025
BEIJING, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Cheer Holding, Inc. (NASDAQ: CHR) (“Cheer Holding” or the “Company”), a leading provider of advanced mobile internet infrastructure and platform services, issues a correction to it prior press release dated July …
Mersana Therapeutics to Host Second Quarter 2025 Conference Call on August 13, 2025
GlobeNewswire
·
August 6, 2025
CAMBRIDGE, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on the development of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, …
Lead Real Estate Co., Ltd Announces the Start of a New Business Operation, “Master Lease Business”
GlobeNewswire
·
August 6, 2025
TOKYO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Lead Real Estate Co., Ltd (Nasdaq: LRE) (“LRE” or “the Company”), a Japanese real estate developer of luxury residential properties including single-family homes and condominiums across Tokyo, Kanagawa Prefecture …
PDS Biotech Announces Conference Call and Webcast for Second Quarter 2025 Financial Results
GlobeNewswire
·
August 6, 2025
PRINCETON, N.J., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced …
Cardurion Pharmaceuticals Completes Enrollment in Phase 2 CYCLE Trials Evaluating CRD-750, a Novel PDE9 inhibitor, in Heart Failure
GlobeNewswire
·
August 6, 2025
CRD-750 is the first clinical-stage PDE9 inhibitor to be evaluated in patients in both types of chronic heart failure The CYCLE-1-REF trial is evaluating patients with heart failure with reduced ejection fraction (HFrEF), and the CYCLE-2-PEF trial is …
Lancaster Resources Expands Market Engagement Through Investor Relations Agreement with Ora IR
GlobeNewswire
·
August 6, 2025
VANCOUVER, British Columbia, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Lancaster Resources Inc. (CSE:LCR) (OTC Pink:LANRF) (FRA:6UF0) (“Lancaster” or the “Company”), a junior resource company advancing gold, uranium and polymetallic projects across North America …
MMA.INC Reports 128%* Annualized Revenue Growth for BJJLink, Driven by Explosive SaaS Subscription Growth in first 7 months of 2025
GlobeNewswire
·
August 6, 2025
Highlights SaaS Subscription Growth Surges over 188%** annualized, highlighting strong market adoption and fueled by rapid onboarding of BJJ academies and strong upsell activity Total Annualized Revenue Growth exceeds 128%* across SaaS and transaction …
Hello Nancy Named 2025 Women’s Wellness Tech Award Winner
GlobeNewswire
·
August 6, 2025
Sheung Wan, Hong Kong, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Hello Nancy, the innovative wellness brand championing female empowerment and self-care, today announced it has been named a winner of the prestigious 2025 Women’s Wellness Tech Award. The award …
IREN July 2025 Monthly Update
GlobeNewswire
·
August 6, 2025
NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (together with its subsidiaries, “IREN” or “the Company”) today published its monthly update for July 2025. July Highlights Record monthly revenue and hardware profit3 AI Cloud …
Forte Minerals Engages Strategic Advisors, Expands Capital Markets Team, and Launches AI-Powered Investor Tool
GlobeNewswire
·
August 6, 2025
VANCOUVER, British Columbia, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Forte Minerals Corp. (“Forte” or the “Company”) (CSE: CUAU) (OTCQB: FOMNF) (Frankfurt: 2OA), is pleased to announce the expansion of its capital markets capabilities with three strategic …
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 6, 2025
RESEARCH TRIANGLE PARK, N.C., Aug. 06, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted 10 newly-hired employees stock options to purchase an …
Entrada Therapeutics Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 6, 2025
-- First patient dosed in ELEVATE-44-201 with data from first patient cohort anticipated in H1 2026 -- -- Initiated ELEVATE-45-201 and on track to dose the first patient in Q3 2025 -- -- Multiple clinical trial sites in U.K. and EU activated for ELEVATE-44 …
Nevada Lithium Announces Robust Preliminary Economic Assessment, Reporting US$6.83 Billion After-Tax NPV, 32.3% After-Tax IRR & 2.8 Year Capital Payback for its High-Grade Bonnie Claire Lithium Project
GlobeNewswire
·
August 6, 2025
VANCOUVER, British Columbia, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Nevada Lithium Resources Inc. (TSXV: NVLH; OTCQB: NVLHF; FSE: 87K) (“Nevada Lithium” or the “Company”) is pleased to announce the results of an updated Preliminary Economic Assessment (“PEA”) …
Trident Resources to Commence Inaugural 5,000m Drill Program at Contact Lake High-Grade Gold Project, Saskatchewan
GlobeNewswire
·
August 6, 2025
Vancouver, BC, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Trident Resources Corp. (TSX-V: ROCK) (OTCQB: TRDTF) (“Trident” or the “Company”) is pleased to announce an upcoming fully-funded 5,000-metre drill program at its high-grade Contact Lake Gold Project, …